PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling.
Wanderley CWS, Maganin AGM, Adjafre B, Mendes AS, Silva CEA, Quadros AU, Luiz JPM, Silva CMS, Silva NR, Oliveira FFB, Gomes FIF, Restrepo JLJ, Speck-Hernandez CA, Turaça F, Silva GVL, Pigatto GR, Nakaya HI, Mota JM, Barroso-Sousa R, Alves-Filho JC, Cunha TM, Cunha FQ.
Wanderley CWS, et al. Among authors: mota jm.
Cancer Immunol Res. 2022 Nov 2;10(11):1299-1308. doi: 10.1158/2326-6066.CIR-22-0003.
Cancer Immunol Res. 2022.
PMID: 36083496